Lung India
Scope & Guideline
Empowering knowledge for better lung care.
Introduction
Aims and Scopes
- Clinical Research in Respiratory Diseases:
The journal publishes original research articles focused on various respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, and COVID-19. This research often involves clinical trials, observational studies, and case reports that contribute to the understanding of disease mechanisms and patient care. - Innovative Diagnostic Techniques:
Lung India emphasizes the importance of novel diagnostic methodologies, such as endobronchial ultrasound, imaging techniques, and biomarkers, to improve the accuracy of lung disease diagnosis and management. - Public Health and Epidemiology:
The journal addresses public health issues related to lung diseases, including the epidemiology of respiratory conditions in specific populations, the impact of environmental factors, and strategies for disease prevention and health promotion. - Management Guidelines and Consensus Statements:
The publication frequently features guidelines and consensus statements developed by expert panels to standardize treatment approaches for various lung diseases, ensuring that clinicians have access to the latest recommendations. - Interventional Pulmonology:
Research related to minimally invasive procedures and therapies in pulmonary medicine, including bronchoscopy and thoracoscopy, is a key area of focus, highlighting advancements in patient care.
Trending and Emerging
- COVID-19 Research and Sequelae:
The impact of COVID-19 on lung health has become a dominant theme, with numerous studies addressing acute management, long-term sequelae, and the implications for patients with pre-existing respiratory conditions. - Telemedicine and Remote Monitoring:
The rise of telemedicine as a vital tool for managing respiratory diseases has gained traction, particularly during the pandemic, leading to increased research on its effectiveness and implementation in clinical practice. - Personalized and Precision Medicine:
There is a growing interest in personalized treatment approaches for respiratory diseases, focusing on biomarkers and genetic factors that influence treatment responses, especially in conditions like asthma and COPD. - Management of Drug-Resistant Tuberculosis:
Research on innovative strategies and therapies for managing drug-resistant tuberculosis has increased, reflecting the urgent need to address this global health challenge. - Environmental and Occupational Lung Diseases:
Emerging studies focus on the relationship between environmental exposures, such as air pollution, and lung diseases, emphasizing the need for public health interventions and awareness.
Declining or Waning
- Traditional Tuberculosis Studies:
While tuberculosis remains a significant health issue, there has been a noticeable decline in the number of studies solely focused on traditional tuberculosis treatments and diagnostics, as the field has shifted towards addressing multi-drug resistant strains and co-infections. - General Respiratory Infections:
Research on common respiratory infections, such as pneumonia caused by non-specific pathogens, appears to be waning, possibly due to a greater emphasis on more complex or emerging respiratory diseases such as COVID-19 and its sequelae. - Longitudinal Studies on Non-communicable Diseases:
There has been a reduction in longitudinal studies examining the long-term effects of non-communicable respiratory diseases, as the focus has shifted towards acute respiratory conditions and their immediate management. - Pediatric Respiratory Diseases:
The frequency of research focusing specifically on pediatric respiratory diseases has decreased, potentially due to a growing emphasis on adult respiratory conditions and the impact of COVID-19 on adult populations. - Traditional Clinical Trials for Established Therapies:
The journal has seen fewer articles reporting on traditional clinical trials for established therapies, as there is a shift towards exploring novel therapies and personalized medicine in respiratory care.
Similar Journals
Pulmonary Medicine
Empowering Clinicians with Cutting-edge InsightsPulmonary Medicine, published by HINDAWI LTD, stands as a prestigious open-access journal since 2010, dedicated to advancing the field of pulmonary and respiratory medicine. Located in Egypt, this journal is indexed with an ISSN of 2090-1836 and an E-ISSN of 2090-1844, and it has attained a commendable Q2 ranking in both the miscellaneous medicine and pulmonary health categories, indicative of its significant impact and quality. With an impressive Scopus ranking of #15 out of 155 in the pulmonary and respiratory medicine category, the journal is positioned in the 90th percentile, highlighting its relevance and contribution to ongoing research. The journal aims to publish high-quality original research, reviews, and clinical studies that address pressing issues in pulmonary health, making it a vital resource for researchers, clinicians, and students seeking to enhance their understanding and practice in respiratory medicine. By embracing an open-access model, Pulmonary Medicine provides a platform for disseminating knowledge, fostering collaboration, and driving innovation within the global scientific community.
THORAX
Elevating respiratory research to new heights.THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.
Egyptian Journal of Bronchology
Advancing respiratory health through open access research.Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.
Pulmonology
Elevating knowledge and practice in pulmonary medicine.Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.
Egyptian Journal of Chest Diseases and Tuberculosis
Transforming knowledge into practice for better respiratory care.The Egyptian Journal of Chest Diseases and Tuberculosis is a premier Open Access journal published by Wolters Kluwer Medknow Publications, focusing on the latest advancements in the fields of respiratory diseases, pulmonary medicine, and tuberculosis management. With an ISSN of 0422-7638 and an E-ISSN of 2090-9950, this journal aims to disseminate high-quality research, reviews, and clinical insights that advance the understanding and treatment of chest diseases. Since its transition to Open Access in 2018, the journal has garnered increased visibility, enabling researchers across the globe to contribute and access valuable content without barriers. Situated in India, the journal is dedicated to bridging the gap between clinical practice and research, emphasizing the significance of innovative therapeutic strategies and public health approaches in combating respiratory illnesses. We invite researchers, healthcare professionals, and students to engage with our publications as we continue to foster knowledge and foster collaboration within the global medical community.
RESPIRATION
Illuminating the Path in Pulmonary and Respiratory MedicineRESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.
Tuberculosis and Respiratory Diseases
Uncovering breakthroughs in tuberculosis research.Tuberculosis and Respiratory Diseases is a leading open-access journal published by THE KOREAN ACADEMY OF TUBERCULOSIS & RESPIRATORY DISEASES, dedicated to disseminating knowledge in the fields of infectious diseases and pulmonary medicine. Since its inception in 1980, the journal has undergone significant growth, currently recognized in the elite Q2 category for both Infectious Diseases and Pulmonary and Respiratory Medicine as of 2023. With an impact factor reflecting its esteemed position—ranked 52nd in its category—it serves as a vital resource for researchers and healthcare professionals seeking cutting-edge insights, studies, and advancements in the management and treatment of respiratory diseases, particularly tuberculosis. The journal is committed to providing open access to its content since 2013, ensuring that critical research is available to scholars worldwide, fostering collaboration and innovation in the global fight against respiratory illnesses.
Canadian Journal of Respiratory Critical Care and Sleep Medicine
Fostering collaboration for groundbreaking medical insights.Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.
Jornal Brasileiro de Pneumologia
Empowering professionals through vital pulmonary research.Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.
Thoracic Research and Practice
Empowering Respiratory Medicine with Open Access InsightsThoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.